Genetics is one of the leading factors in developing prostate cancer. Men with a family history of prostate cancer are more likely to be diagnosed with the disease. Other risk factors include eating fatty foods, obesity, and an increase in age.

Tests to diagnose prostate cancer include:

• Prostate-Specific Antigen (PSA) Test
• Digital Rectal Exam
• Biopsy
• Ultrasound Examination

When your doctor performs a prostate biopsy, they use a grading system to stage and evaluate your prognosis. The stage of your cancer evaluates where in your body the cancer is while the grade evaluates what the cells look like when examined by the pathologist. 

The Gleason Score uses a scale of one to five to describe or grade the cell patterns of the biopsy from normal cells to tumor cells. These patterns are divided into two groups. The first Gleason group is the most prominent pattern of cells and the second Gleason group is the second most prominent cell group. These two grades are added together to determine your Gleason Score and helps determine the risk of spread and how you will be treated.

The Gleason Score is as follows: Gleason 3+3=6 is grade 1 and low risk, Gleason 3+4=7 is grade 2 and is intermediate risk (favorable), Gleason 4+3=7 is grade 3 and intermediate risk (unfavorable), Gleason 4+4=8 is grade 4 and high risk, and Gleason 4+5-=9 or 5+5=10 is grade 5 and considered very high risk. Any grade 5 cells, no matter how small, puts you at a high risk for metastasis or recurrence.

There are many ways to treat prostate cancer, however, one of the most effective is radiation therapy. Prostate cancer treatment Miami: CyberKnife therapy is a painless and minimally invasive alternative cancer treatment. Contact the CyberKnife Prostate Cancer Treatment Center at (800) 204-0455.

CyberKnife is a highly specialized radiation therapy equipment that uses Stereotactic Body Radiation Therapy (SBRT) to treat cancer. 

CyberKnife uses pinpoint accuracy and continual imaging to destroy tumors while leaving surrounding tissue virtually unharmed. CyberKnife is the only radiation therapy equipment that uses 100 to 300 beams of radiation and real-time imaging to treat the prostate with extremely small margins sparing the rectum, bladder and urethra in only 5 treatments. It is non-invasive, painless, and requires no recovery time.

To determine if you are eligible to receive radiation therapy for prostate cancer with the CyberKnife Center of Miami, Dr. Pomper and his team will meet with you for a consultation.

During your consultation, the CyberKnife team will review your medical history, your cancer diagnosis and much more.

Most people do qualify for prostate cancer treatment with CyberKnife radiation therapy. To book your consultation please call our office at (800) 204-0455.